AnalystsWilliam Pickering
William Pickering's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Bottom 12%
#4488 out of 5077 analysts
Average Return
-4.38%
Win Rate
38%6 out of 16
Risk vs Reward
Poor
Good

William Pickering's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Alnylam Pharmaceuticals IncALNY
+96.41%$235.95$463.43
2025-01-06 -
2025-10-24
Buy
Vertex Pharmaceuticals IncVRTX
+41.12%$358.40$505.78
2023-08-01 -
2024-08-01
Buy
Vertex Pharmaceuticals IncVRTX
+39.88%$354.05$495.26
2023-07-28 -
2024-07-26
Buy
Vertex Pharmaceuticals IncVRTX
+36.16%$302.66$412.11
2023-03-20 -
2024-03-20
Buy
Vertex Pharmaceuticals IncVRTX
+15.53%$346.36$400.16
2023-05-02 -
2024-05-02
Buy

William Pickering Analyst Color

Get additional color on William Pickering's coverage of popular stocks

William Pickering's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Regeneron Pharmaceuticals IncREGN
3Buy$781.00+35.13%Maintains
2 months ago
Sarepta Therapeutics IncSRPT
1Hold$13.00-43.01%Initiates Coverage On
3 months ago
Alnylam Pharmaceuticals IncALNY
2Buy$310.00-33.11%Maintains
10 months ago
Arrowhead Pharmaceuticals IncARWR
2Hold$24.00-36.84%Maintains
a year ago
Biohaven LtdBHVN
2Buy$66.00N/AMaintains
a year ago
Biomarin Pharmaceutical IncBMRN
4Buy$90.00N/AMaintains
a year ago
Vertex Pharmaceuticals IncVRTX
4Buy$390.00N/AMaintains
2 years ago
Intellia Therapeutics IncNTLA
1Buy$54.00N/AInitiates Coverage On
3 years ago
Beam Therapeutics IncBEAM
1Hold$37.00N/AInitiates Coverage On
3 years ago
Allogene Therapeutics IncALLO
1Hold$6.00N/AInitiates Coverage On
3 years ago
Crispr Therapeutics AgCRSP
1Hold$44.00N/AInitiates Coverage On
3 years ago
Ionis Pharmaceuticals IncIONS
1Sell$31.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.